Plasma monocyte chemoattractant protein‐1 (MCP‐1) and macrophage inflammatory protein‐1α are increased in patients with polycystic ovary syndrome (PCOS) and associated with adiposity, but unaffected by pioglitazone treatment

Obesity is associated with macrophage accumulation in adipose tissue

Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · see citing works

Abdominal obesity and metabolic syndrome

Després, J.-P., & Lemieux, I. (2006) · Nature · doi:10.1038/nature05488 · Cited by 4,354 · see citing works

Men at risk: occupation and male infertility.

Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,219 · see citing works

PRACTICAL STATISTICS FOR MEDICAL RESEARCH

Ludbrook, J. (1991) · Australian and New Zealand Journal of Surgery · doi:10.1111/j.1445-2197.1991.tb00019.x · Cited by 1,219 · see citing works

Monocyte chemoattractant protein 1 in obesity and insulin resistance

Sartipy, P., & Loskutoff, D. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1133870100 · Cited by 1,201 · see citing works

Reduction of Macrophage Infiltration and Chemoattractant Gene Expression Changes in White Adipose Tissue of Morbidly Obese Subjects After Surgery-Induced Weight Loss

Cancello, R., Henegar, C., Viguerie, N., Taleb, S., Poitou, C., Rouault, C., Coupaye, M., Pelloux, V., Hugol, D., Bouillot, J.-L., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2277 · Cited by 1,164 · see citing works

Androgen Excess in Women: Experience with Over 1000 Consecutive Patients

Azziz, R., Sanchez, L. A., Knochenhauer, E. S., Moran, C., Lazenby, J., Stephens, K. C., Taylor, K., & Boots, L. R. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031122 · Cited by 1,132 · see citing works

Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients

Miyazaki, Y., Mahankali, A., Matsuda, M., Mahankali, S., Hardies, J., Cusi, K., Mandarino, L. J., & DeFronzo, R. A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.6.8567 · Cited by 726 · see citing works

The Effects of Rosiglitazone on Insulin Sensitivity, Lipolysis, and Hepatic and Skeletal Muscle Triglyceride Content in Patients With Type 2 Diabetes

Mayerson, A. B., Hundal, R. S., Dufour, S., Lebon, V., Befroy, D., Cline, G. W., Enocksson, S., Inzucchi, S. E., Shulman, G. I., & Petersen, K. F. (2002) · Diabetes · doi:10.2337/diabetes.51.3.797 · Cited by 647 · see citing works

Macrophage Infiltration into Omental <i>Versus</i> Subcutaneous Fat across Different Populations: Effect of Regional Adiposity and the Comorbidities of Obesity

Harman-Boehm, I., Blüher, M., Redel, H., Sion-Vardy, N., Ovadia, S., Avinoach, E., Shai, I., Klöting, N., Stumvoll, M., Bashan, N., et al. (2007) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jc.2006-1811 · Cited by 574 · see citing works

Regulation of adipocytokines and insulin resistance

Faßhauer, M., & Paschke, R. (2003) · Diabetologia · doi:10.1007/s00125-003-1228-z · Cited by 543 · see citing works

Monocyte Chemoattractant Protein-1 Release Is Higher in Visceral than Subcutaneous Human Adipose Tissue (AT): Implication of Macrophages Resident in the AT

Bruun, J. M., Lihn, A. S., Pedersen, S. B., & Richelsen, B. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1696 · Cited by 535 · see citing works

Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects

Christiansen, T., Richelsen, B., & Bruun, J. M. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802839 · Cited by 411 · see citing works

Evidence for a Potent Antiinflammatory Effect of Rosiglitazone

Mohanty, P., Aljada, A., Ghanim, H., Hofmeyer, D., Tripathy, D., Syed, T., Al-Haddad, W., Dhindsa, S., & Dandona, P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032103 · Cited by 375 · see citing works

Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome

Tang, T. H., Norman, R. J., Balen, A. H., & Lord, J. M. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003053 · Cited by 369 · see citing works

Genes Involved in Fatty Acid Partitioning and Binding, Lipolysis, Monocyte/Macrophage Recruitment, and Inflammation Are Overexpressed in the Human Fatty Liver of Insulin-Resistant Subjects

Westerbacka, J., Kolak, M., Kiviluoto, T. A., Arkkila, P. E. T., Sirén, J., Hamsten, A., Fisher, R. M., & Yki‐Järvinen, H. (2007) · Diabetes · doi:10.2337/db07-0156 · Cited by 354 · see citing works

Cytokines and steroidogenesis

Bornstein, S., Rutkowski, H., & Vrezas, I. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.11.022 · Cited by 340 · see citing works

POSITION STATEMENT: Glucose Intolerance in Polycystic Ovary Syndrome—A Position Statement of the Androgen Excess Society

Salley, K. E. S., Wickham, E. P., Cheang, K. I., Essah, P. A., Karjane, N. W., & Nestler, J. E. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1549 · Cited by 339 · see citing works

Hirsutism

Rosenfield, R. L. (2005) · New England Journal of Medicine · doi:10.1056/nejmcp033496 · Cited by 304 · see citing works

Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome

Kirchengast, S. (2001) · Human Reproduction · doi:10.1093/humrep/16.6.1255 · Cited by 291 · see citing works

Metformin Reduces Serum C-Reactive Protein Levels in Women with Polycystic Ovary Syndrome

Morin-Papunen, L. C., Rautio, K., Ruokonen, A., Hedberg, P. S. M., Puukka, M., & Tapanainen, J. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021688 · Cited by 245 · see citing works

Fertility and Sterility

Kovanci, E. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.01.094 · Cited by 204 · see citing works

Increased Plasma Concentration of Macrophage Migration Inhibitory Factor (MIF) and MIF mRNA in Mononuclear Cells in the Obese and the Suppressive Action of Metformin

Dandona, P., Aljada, A., Ghanim, H., Mohanty, P., Tripathy, C., Hofmeyer, D., & Chaudhuri, A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0436 · Cited by 182 · see citing works

Ethinylestradiol-Drospirenone, Flutamide-Metformin, or Both for Adolescents and Women with Hyperinsulinemic Hyperandrogenism: Opposite Effects on Adipocytokines and Body Adiposity

Ibáñez, L., & de Zegher, F. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031281 · Cited by 172 · see citing works

Effects of Simvastatin and Oral Contraceptive Agent on Polycystic Ovary Syndrome: Prospective, Randomized, Crossover Trial

Banaszewska, B., Pawelczyk, L., Spaczynski, R. Z., Dziura, J., & Duleba, A. J. (2007) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jc.2006-1988 · Cited by 143 · see citing works

Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls

Glintborg, D., Andersen, M., Hagen, C., Frystyk, J., Hulstrøm, V., Flyvbjerg, A., & Hermann, A. P. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02207 · Cited by 133 · see citing works

Prevalence of endocrine diseases and abnormal glucose tolerance tests in 340 caucasian premenopausal women with hirsutism as the referral diagnosis

Glintborg, D., Henriksen, J. E., Andersen, M., Hagen, C., Hangaard, J., Rasmussen, P. E., Schousboe, K., & Hermann, A. P. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.06.040 · Cited by 126 · see citing works

ABNORMAL ANDROGEN AND OESTROGEN METABOLISM IN MEN WITH STEROID SULPHATASE DEFICIENCY AND RECESSIVE X‐LINKED ICHTHYOSIS

Lykkesfeldt, G., BENNETT, P., Lykkesfeldt, A. E., Mičić, S., MØLLER, S., & Svenstrup, B. (1985) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1985.tb01096.x · Cited by 105 · see citing works

Monocyte chemotactic protein-1 and its role in insulin resistance

Sell, H., & Eckel, J. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3281338546 · Cited by 104 · see citing works

The android woman – a risky condition

Björntorp, P. A. (1996) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1996.364690000.x · Cited by 103 · see citing works

Association of Systemic Concentrations of Macrophage Migration Inhibitory Factor With Impaired Glucose Tolerance and Type 2 Diabetes

Herder, C., Kolb, H., Köenig, W., Haastert, B., Müller-Scholze, S., Rathmann, W., Holle, R., Thorand, B., & Wichmann, H. ‐. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1474 · Cited by 95 · see citing works

High neutrophil count in girls and women with hyperinsulinaemic hyperandrogenism: normalization with metformin and flutamide overcomes the aggravation by oral contraception

Ibáñez, L., Jaramillo, A. M. A., Ferrer, A., & de Zegher, F. (2005) · Human Reproduction · doi:10.1093/humrep/dei072 · Cited by 94 · see citing works

Effect of macrophage migration inhibitory factor (MIF) gene variants and MIF serum concentrations on the risk of type 2 diabetes: results from the MONICA/KORA Augsburg Case–Cohort Study, 1984–2002

Herder, C., Klopp, N., Baumert, J. J., Müller‐Nurasyid, M., Khuseyinova, N., Meisinger, C., Martin, S., Illig, T., Köenig, W., & Thorand, B. (2007) · Diabetologia · doi:10.1007/s00125-007-0800-3 · Cited by 92 · see citing works

Mevastatin inhibits ovarian theca–interstitial cell proliferation and steroidogenesis

Izquierdo, D. M., Foyouzi, N., Kwintkiewicz, J., & Dulęba, A. J. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.03.037 · Cited by 90 · see citing works

Body Fat Distribution in Women With Polycystic Ovary Syndrome

Douchi, T. (1995) · Obstetrics and Gynecology · doi:10.1016/0029-7844(95)00250-u · Cited by 81 · see citing works

Cytokine secretion by human adipocytes is differentially regulated by adiponectin, AICAR, and troglitazone

Sell, H., Dietze‐Schroeder, D., Eckardt, K., & Eckel, J. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.03.010 · Cited by 78 · see citing works

Gender-related effects of chronic non-malignant pain and opioid therapy on plasma levels of macrophage migration inhibitory factor (MIF)

Aloisi, A. M., Pari, G., Ceccarelli, I., Vecchi, I., Ietta, F., Lodi, L., & Paulesu, L. R. (2005) · Pain · doi:10.1016/j.pain.2005.02.019 · Cited by 75 · see citing works

Most of the interleukin 1 receptor antagonist, cathepsin S, macrophage migration inhibitory factor, nerve growth factor, and interleukin 18 release by explants of human adipose tissue is by the non–fat cells, not by the adipocytes

Fain, J. N., Tichansky, D. S., & Madan, A. K. (2006) · Metabolism · doi:10.1016/j.metabol.2006.04.008 · Cited by 73 · see citing works

Hirsutism

Rittmaster, R. S. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07252-2 · Cited by 73 · see citing works

Total and high molecular weight (HMW) adiponectin levels and measures of glucose and lipid metabolism following pioglitazone treatment in a randomized placebo‐controlled study in polycystic ovary syndrome

Glintborg, D., Frystyk, J., Højlund, K., Andersen, K. K., Henriksen, J. E., Hermann, A. P., Hagen, C., Flyvbjerg, A., & Andersen, M. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03015.x · Cited by 69 · see citing works

Effect of pioglitazone on glucose metabolism and luteinizing hormone secretion in women with polycystic ovary syndrome

Glintborg, D., Hermann, A. P., Andersen, M., Hagen, C., Beck‐Nielsen, H., Veldhuis, J. D., & Henriksen, J. E. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.12.067 · Cited by 68 · see citing works

Obesity, macrophage migration inhibitory factor, and weight loss

Church, T. S., Willis, M. S., Priest, E. L., LaMonte, M. J., Earnest, C. P., Wilkinson, W. J., Wilson, D. A., & Giroir, B. P. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0802942 · Cited by 60 · see citing works

Monocyte Chemoattractant Protein‐1 in Obesity and Type 2 Diabetes. Insulin Sensitivity Study

Chacón, M. R., Fernández‐Real, J. M., Richart, C., Megía, A., Gómez, J. M., Miranda, M., Caubet, E., Pastor, R., Noguera, C. M., Vilarrasa, N., et al. (2007) · Obesity · doi:10.1038/oby.2007.578 · Cited by 50 · see citing works

Medroxyprogesterone acetate versus norethisterone: effect on estradiol-induced changes of markers for endothelial function and atherosclerotic plaque characteristics in human female coronary endothelial cell cultures

Mueck, A. O., Seeger, H., & Wallwiener, D. R. (2002) · Menopause The Journal of The North American Menopause Society · doi:10.1097/00042192-200207000-00008 · Cited by 46 · see citing works

Pioglitazone Treatment Increases Spontaneous Growth Hormone (GH) Secretion and Stimulated GH Levels in Polycystic Ovary Syndrome

Glintborg, D., Støving, R. K., Hagen, C., Hermann, A. P., Frystyk, J., Veldhuis, J. D., Flyvbjerg, A., & Andersen, M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0615 · Cited by 43 · see citing works

Higher bone mineral density in Caucasian, hirsute patients of reproductive age. Positive correlation of testosterone levels with bone mineral density in hirsutism

Glintborg, D., Andersen, M., Hagen, C., & Hermann, A. P. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02280.x · Cited by 40 · see citing works

Circulating chemoattractants RANTES, negatively related to endogenous androgens, and MCP-1 are differentially suppressed by hormone therapy and raloxifene

Christodoulakos, G., Lambrinoudaki, I. V., Economou, E. V., Papadias, C. B., Vitoratos, N., Panoulis, C., Kouskouni, E. E., Vlachou, S. A., & Creatsas, G. C. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.05.045 · Cited by 24 · see citing works

Investigations in the assessment and management of patients with hirsutism

Barth, J. H. (1997) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/00001703-199706000-00010 · Cited by 15 · see citing works

Hirsutism: Definitions and Etiology

Erkkola, R., & Ruutiainen, K. (1990) · Annals of Medicine · doi:10.3109/07853899009147250 · Cited by 13 · see citing works

[Association of monocyte chemoattractant protein-1 and the clinical characteristics of polycystic ovary syndrome: analysis of 65 cases].

Hu, W., Qiao, J., & Li, M. (2007) · PubMed · Cited by 8 · see citing works

Chronic Low Grade Inflammation in Pathogenesis of PCOS

Rudnicka, E., Suchta, K., Grymowicz, M., Calik-Ksepka, A., Smolarczyk, K., Duszewska, A. M., Smolarczyk, R., & Meczekalski, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073789 · Cited by 680 · see citing works

Is PCOS an inflammatory process?

Duleba, A. J., & Dokras, A. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.11.023 · Cited by 327 · see citing works

Polycystic ovary syndrome, adipose tissue and metabolic syndrome

Delitala, A. P., Capobianco, G., Delitala, G., Cherchi, P. L., & Dessole, S. (2017) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-017-4429-2 · Cited by 159 · see citing works

The intersection of metformin and inflammation

Bharath, L. P., & Nikolajczyk, B. S. (2021) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00604.2020 · Cited by 134 · see citing works

A Lower-Carbohydrate, Higher-Fat Diet Reduces Abdominal and Intermuscular Fat and Increases Insulin Sensitivity in Adults at Risk of Type 2 Diabetes

Gower, B. A., & Goss, A. M. (2015) · The Journal of Nutrition · doi:10.3945/jn.114.195065 · Cited by 98 · see citing works

Therapeutic Effects and Mechanisms of Herbal Medicines for Treating Polycystic Ovary Syndrome: A Review

Kwon, C.-Y., Cho, I.-H., & Park, K. S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01192 · Cited by 52 · see citing works

Elevated Circulating Levels of Macrophage Migration Inhibitory Factor in Polycystic Ovary Syndrome

González, F., Rote, N. S., Minium, J., Weaver, A. L., & Kirwan, J. P. (2010) · Cytokine · doi:10.1016/j.cyto.2010.06.008 · Cited by 35 · see citing works

The comparison of free androgen index and serum free testosterone levels in women with hirsutism or polycystic ovary syndrome

Güngör, O. T., Erden, G., Bal, C., Uğuz, N., Sezer, S., Özdemir, Ş., Çelik, H. T., & Yıldırımkaya, M. (2011) · Journal of Clinical and Experimental Investigations · doi:10.5799/ahinjs.01.2011.02.0230 · Cited by 6 · see citing works

Insulin sensitivity does not differentiate by hirsutism in non-obese women with polycystic ovary syndrome

Çoşar, E., Köken, G., Şahin, F. K., et al. (2008) · Endocrine Journal · doi:10.1507/endocrj.k07-069 · Cited by 7 · see citing works

A Study of association of polycystic ovary syndrome with hirsutism- A prospective observational study in a Tertiary Care Hospital

Varma, K., & Aujla, S. S. (2021) · IP Indian Journal of Clinical and Experimental Dermatology

Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels

Fruzzetti, F., Perini, D., Lazzarini, V., Parrini, D., & Genazzani, A. R. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.004 · Cited by 95 · see citing works

The polycystic ovary syndrome. 1. Pathogenesis.

White, M. C., & Turner, E. I. (1994) · PubMed · Cited by 3 · see citing works